CLOS
MRNA icon

Compagnie Lombard Odier SCmA’s Moderna MRNA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,400
Closed -$1K – 623
2022
Q1 		$1K Buy
1,400
+700
+100% +$118K ﹤0.01% 593
2021
Q4 		$16K Buy
+700
New +$205K ﹤0.01% 601
2021
Q2 		– Sell
-600
Closed -$8K – 668
2021
Q1 		$8K Buy
+600
New +$86.9K ﹤0.01% 615

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Compagnie Lombard Odier SCmA's MRNA Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA reduced its Moderna (MRNA) stake by 11% in Q2 2026, selling an estimated $732K and leaving 111,582 shares worth $7.81M. The position accounts for 0.08% of the portfolio, ranked #109.

Compagnie Lombard Odier SCmA first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $34.2M in Q3 2021. 415 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 111,582 shares of Moderna worth $7.81M as of Q2 2026.
  • Compagnie Lombard Odier SCmA sold 14,156 Moderna shares in Q2 2026, an estimated $732K.
  • Moderna made up 0.08% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #109 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Compagnie Lombard Odier SCmA's Moderna position peaked at $34.2M in Q3 2021.
  • 415 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.